库欣综合征患者髋部骨折风险:一项基于人群的队列研究
这项以色列全国性回顾性匹配队列研究纳入606例内源性库欣综合征患者和2988例对照,发现患者髋部骨折风险轻度升高(HR 1.57,95%CI 1.0-2.5;p=0.05),尤其在库欣病患者中更高(HR 2.2,95%CI 1.07-4.75;p=0.03),且缓解后风险未见显著降低。
要点
- 库欣综合征患者髋部骨折风险轻度升高(HR 1.57,95%CI 1.0-2.5;p=0.05)。
- 库欣病患者风险更高(HR 2.2,95%CI 1.07-4.75;p=0.03),肾上腺来源者无显著升高。
- 缓解与否髋部骨折风险无显著差异(HR 1.14,95%CI 0.4-3.0)。
核心结论
- 内源性库欣综合征可能与髋部骨折风险升高相关,尤其在库欣病患者中,主要由诊断时年龄较大和既存骨质疏松驱动,缓解后风险未见显著降低。
研究设计与样本
- 以色列Clalit健康服务数据库的全国性回顾性匹配队列研究,纳入2000至2023年诊断的内源性库欣综合征患者,按年龄、性别、社会经济地位和体重指数1:5匹配对照。
主要发现
- 共纳入606例库欣综合征患者和2988例匹配对照,诊断时平均年龄47.8±17.1岁,65.3%为女性。
- 库欣综合征患者随访14.0±6.5年,对照随访14.5±6.5年。
- 髋部骨折发生于3.9%的库欣综合征患者和2.5%的匹配对照,竞争风险分析显示轻度关联(HR 1.57,95%CI 1.0-2.5;p=0.05)。
- 库欣病患者髋部骨折风险更高(HR 2.2,95%CI 1.07-4.75;p=0.03),肾上腺来源者无显著升高(HR 1.3,95%CI 0.6-2.8)。
- 未缓解患者髋部骨折发生率4.3%,缓解患者3.6%,组间无显著差异(HR 1.14,95%CI 0.4-3.0);多变量分析中,诊断时年龄较大和既存骨质疏松与髋部骨折风险增加独立相关。
临床怎么用
- 对库欣综合征患者应早期进行骨折风险评估和针对性骨质疏松管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Cushing's syndrome causes bone loss, yet the risk of hip fractures remains poorly defined. In this nationwide cohort, patients showed a modestly increased risk of hip fracture, particularly soon after diagnosis. These results underscore the importance of early osteoporosis screening and timely fracture prevention strategies. BACKGROUND: Glucocorticoid-induced osteoporosis is a common complication of Cushing's syndrome (CS). While the increased risk for vertebral fractures is well-established, evidence regarding hip fracture risk is limited. This study investigates the association between endogenous CS and hip fracture risk and examines the effect of remission on this risk. METHODS: A nationwide retrospective matched-cohort study was conducted using the Clalit Health Services database in Israel, including patients diagnosed with endogenous CS between 2000 and 2023. Patients with CS were matched 1:5 to controls based on age, sex, socioeconomic status, and body mass index. The primary outcome was the first diagnosis of hip fractures following the diagnosis of CS. Patients with a history of hip fractures prior to CS diagnosis were excluded. RESULTS: The study included 606 patients with CS and 2,988 matched controls, with a mean age at diagnosis of 47.8 ± 17.1 years; 65.3% were female. Follow-up durations were 14.0 ± 6.5 years for patients with CS and 14.5 ± 6.5 years for controls. Hip fractures occurred in 3.9% of patients with CS and 2.5% of matched controls, corresponding to a modest association in competing risk analysis (HR 1.57, 95% CI 1.0-2.5; p = 0.05). The risk was higher among patients with Cushing's disease (CD) (HR 2.2, 95% CI 1.07-4.75; p = 0.03) but not in those with an adrenal source (HR 1.3, 95% CI 0.6-2.8). Analysis by remission status showed that hip fractures occurred in 4.3% of patients without remission and 3.6% of those in remission, with no significant difference between groups (HR 1.14, 95% CI 0.4-3.0). In multivariate analysis, older age at CS diagnosis and pre-existing osteoporosis were independently associated with an increased risk of hip fracture. CONCLUSION: Endogenous Cushing's syndrome may be associated with an increased hip fracture risk, particularly in CD, driven mainly by older age at diagnosis and pre-existing osteoporosis, with no significant risk reduction after remission. These findings underscore the need for early fracture risk assessment and targeted osteoporosis management in patients with CS.
引用
- Masri-Iraqi H, Rudman Y, Shochat T, et al. Hip fracture risk in patients with Cushing's syndrome: a population-based cohort study. Osteoporos Int. 2026. PMID: 42911249. doi:10.1007/s00198-026-08230-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。